Annual Cash & Cash Equivalents:
$161.44M+$81.51M(+101.99%)Summary
- As of today, TERN annual cash & cash equivalents is $161.44 million, with the most recent change of +$81.51 million (+101.99%) on December 31, 2024.
- During the last 3 years, TERN annual cash & cash equivalents has risen by +$113.74 million (+238.45%).
- TERN annual cash & cash equivalents is now at all-time high.
Performance
TERN Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$295.63M-$19.81M(-6.28%)Summary
- As of today, TERN quarterly cash & cash equivalents is $295.63 million, with the most recent change of -$19.81 million (-6.28%) on September 30, 2025.
- Over the past year, TERN quarterly cash & cash equivalents has dropped by -$77.14 million (-20.69%).
- TERN quarterly cash & cash equivalents is now -20.69% below its all-time high of $372.78 million, reached on September 30, 2024.
Performance
TERN Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TERN Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +102.0% | -20.7% |
| 3Y3 Years | +238.4% | +57.9% |
| 5Y5 Years | +1209.6% | +294.9% |
TERN Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +238.4% | -20.7% | +57.9% |
| 5Y | 5-Year | at high | +1209.6% | -20.7% | +294.9% |
| All-Time | All-Time | at high | +1209.6% | -20.7% | +2298.3% |
TERN Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $295.63M(-6.3%) |
| Jun 2025 | - | $315.44M(-5.6%) |
| Mar 2025 | - | $334.26M(-6.7%) |
| Dec 2024 | $161.44M(+102.0%) | $358.16M(-3.9%) |
| Sep 2024 | - | $372.78M(+65.5%) |
| Jun 2024 | - | $225.30M(-6.4%) |
| Mar 2024 | - | $240.65M(-8.6%) |
| Dec 2023 | $79.93M(-44.2%) | $263.44M(-1.2%) |
| Sep 2023 | - | $266.60M(-6.7%) |
| Jun 2023 | - | $285.60M(-4.0%) |
| Mar 2023 | - | $297.53M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $143.24M(+200.3%) | $283.11M(+51.2%) |
| Sep 2022 | - | $187.29M(+34.0%) |
| Jun 2022 | - | $139.81M(-7.6%) |
| Mar 2022 | - | $151.27M(-8.9%) |
| Dec 2021 | $47.70M(-36.3%) | $165.98M(-6.3%) |
| Sep 2021 | - | $177.20M(-4.3%) |
| Jun 2021 | - | $185.08M(-5.4%) |
| Mar 2021 | - | $195.58M(+161.3%) |
| Dec 2020 | $74.85M(+507.2%) | $74.85M(+507.2%) |
| Dec 2019 | $12.33M(-85.1%) | $12.33M |
| Dec 2018 | $82.52M | - |
FAQ
- What is Terns Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Terns Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Terns Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of TERN is $161.44M
What is the all-time high annual cash & cash equivalents for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $161.44M
What is Terns Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, TERN annual cash & cash equivalents has changed by +$81.51M (+101.99%)
What is Terns Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TERN is $295.63M
What is the all-time high quarterly cash & cash equivalents for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $372.78M
What is Terns Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, TERN quarterly cash & cash equivalents has changed by -$77.14M (-20.69%)